Injectable Drug Delivery Market

Table of Content

1. INTRODUCTION
   1. Study Assumptions and Market Definition
   2. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. Market Overview
   2. Market Drivers
      1. Increasing Prevalence of Chronic Disease
   3. Market Restraints
      1. High Development Costs
      2. Safety Concerns and Regulatory Challenges
   4. Market Opportunity
      1. Rising Demandfor Biosimilars and Generic Medicines
   5. Market Trends
      1. Shift Towards Self-administration Devices
      2. Integration of Digital Health and Connectivity
5. MARKET SEGMENTATION
   1. By Type
      1. Injectable Drug Delivery Devices
      2. Injectable Drug Delivery Formulation
   2. By Formulation Packaging
      1. Ampoules
      2. Vials
      3. Cartridges
      4. Bottles
   3. By Therapeutic Application
      1. Autoimmune Diseases
      2. Hormonal Disorders
      3. Orphan Diseases
      4. Cancer
      5. Others
   4. By Usage Pattern
      1. Curative Care
      2. Immunization
      3. Other
   5. By Site of Administration
      1. Skin
      2. Circulatory/Musculoskeletal System
      3. Organs
      4. Central Nervous System
   6. By End User
      1. Hospitals and Clinics
      2. Home Care Settings
      3. Others
   7. By Key Geographic Regions
      1. North America
         1. United States
         2. Canada
         3. Mexico
      2. Europe
         1. Germany
         2. United Kingdom
         3. France
         4. Italy
         5. Spain
         6. Rest of Europe
      3. Asia Pacific
         1. China
         2. Japan
         3. India
         4. Australia
         5. South Korea
         6. Rest of Asia Pacific
      4. Middle East and Africa
         1. GCC
         2. South Africa
         3. Rest of Middle East and Africa
      5. South America
         1. Brazil
         2. Argentina
         3. Rest of South America
6. COMPETITIVE LANDSCAPE
   1. Company Profile
      1. Abbott
      2. AstraZeneca
      3. AbbVie Inc.
      4. Baxter
      5. B.D.
      6. Eli Lilly and Company
      7. E3D Elcam Drug Delivery Devices
      8. Gerresheimer AG
      9. Insulet Corporation
      10. Johnson & Johnson Private Limited
      11. Mylan N.V.
      12. Novo Nordisk A/S
      13. Novartis AG
      14. Pfizer Inc.
      15. Schott AG
      16. SHL Medical AG
      17. Sanofi
      18. Terumo Medical Corporation
      19. Teva Pharmaceutical Industries Ltd.
      20. West Pharmaceutical Services, Inc.
      21. Ypsomed AG
7. MARKET OPPORTUNITIES AND FUTURE TREND

Frequently Asked Questions

Q.1. What is the projected market value of the global injectable drug deliverymarket?

The global market of injectable drug deliveryis projected to reach USD65.68Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global injectable drug delivery market?

The global injectable drug deliverymarket has an estimated annual growth rate of 10.5%.

Q.3. What are the recent trends of injectable drug deliverymarket?

Shift towards self-administration devices and integration of digital health and connectivity are some of the major trends of the market that is projected to boost the market growth in the near future.  

Q.4. Which are the top companies to hold the market share in injectable drug delivery?

The major companies profiled in this report include Abbott, AstraZeneca, AbbVie Inc., Baxter, B.D., Eli Lilly and Company, E3D Elcam Drug Delivery Devices, Gerresheimer AG, Insulet Corporation, Johnson & Johnson Private Limited, Mylan N.V., Novo Nordisk A/S, Novartis AG, Pfizer Inc., Schott AG, SHL Medical AG, Sanofi, Terumo Medical Corporation, Teva Pharmaceutical Industries Ltd., West Pharmaceutical Services, Inc., Ypsomed AG, among others.                                               

Q.5. Which is the largest regional market in the injectable drug delivery?

North America is the largest regional market for injectable drug delivery.